48,201 46,018 46,319 Total liabilities million baht 14,260 13,544 14,428 equity’ Total shareholders million baht 33,941 32,474 31,891 Registered capital million baht 1,259 1,259 1,259 up capital-Paid

% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share

operational systems to scale up franchise operations, while the franchise opportunities are expected to be ready by end of May 2020. Q1/2020 Management Highlights Cost-saving initiatives have been carried out

branch, Central Plaza Bangna branch, and The Mall Bangkapi branch. 3 Continuous expansion of new store format "After You Marketplace" Developed and created more than 17 new products Expand pop-up stores

operated full capacity which resulted Methyl Ester(ME) sales volume of 102,754 tons, increased by 33,549 tons or up by 48% yoy, and FA sales volume of 24,235 tons, grew higher by 4,345 tons or up 22% yoy

first half of 2019, and later in the second half of the year, 2-4 additional branches in Thailand and 1 franchisee branch in Hong Kong are expected to be opened. More Pop-Up Stores have been launched to

have impacts in the future, especially a new round of COVID-19 outbreak. The Company has planned to improve the Pop-up store distribution system to have higher adaptability and prepared necessary human

desserts and beverages, including butter bun, banana cake, cookies, milk tea, coffee, and bottled drinks. Launch a pop-up ice cream soft-serve booth In Q3/2023, the Company launched a pop-up soft-serve ice

scrap materials and tax cards income. 4. Profit from foreign exchanges increased by 77.69 million baht (from 27.75 million baht in 2016 to 105.44 million baht in 2017) due to forward foreign currency

จากปัจจัยอื่นๆ นอกเหนือจากอัตราดอกเบี้ย (forward gap risk) 3% ของฐานะรวม โดยฐานะรวม = | ฐานะ long + ฐานะ short | โดยค่าความเสี่ยงในการมีฐานะในสินค้าโภคภัณฑ์และตัวแปรอื่นจะเท่ากับผลรวมค่าความเสี่ยงตาม (1